Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

Presentation TCT Abstracts Posters 2018

Impact of Smoking Status on Outcomes After Percutaneous Coronary Intervention

Presenter: Juan Wang

September 25, 2018

Presentation TCT 2018

Advances in Digital Health May Help Prevent Cardiovascular Diseases: "E-Prevention"

Presenter: C. Michael Gibson, Mamas Mamas, Mohammad El Tahlawi

September 24, 2018

Presentation TCT 2018

COMPASS Trial Revisited: Weighing Rivaroxaban Secondary Prevention vs DAPT After PCI

Presenter: Deepak L. Bhatt, Tullio Palmerini, Michael Maeng

September 23, 2018

Presentation TCT 2018

LAA Closure 3: Prevention and Management of Complications

Presenter: Habib Gamra, E. Murat Tuzcu

September 23, 2018

Presentation TCT 2018

Topic 5: CIN Prevention Strategies

Presenter: Sripal Bangalore, Somjot S. Brar, Roxana Mehran

September 23, 2018

Presentation TCT 2018

PFO Closure for Primary Prevention?

Presenter: Michael J. Mullen, David E. Thaler, Brian K. Whisenant

September 22, 2018

Presentation The Structural Heart Disease Summit 2018

Incidence, Predictors, Consequences, Prevention, and Treatment of Coronary Occlusion During TAVR: Practical Clinical Guidelines

Presenter: Ariel Finkelstein

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

NO: The Data Are Weak and the Costs Are Prohibitive!

Presenter: John K. Forrest

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

YES: Review of ALL the Data and Common Sense Tell the Story!

Presenter: Axel Linke

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Presenter: Eberhard Grube, Tamim Nazif

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Cedars-Sinai Medical Center (USA)

Presenter: Tarun Chakravarty

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Erasmus University (The Netherlands)

Presenter: Nicolas M. Van Mieghem

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Ulm University (Germany)

Presenter: Julia Seeger

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Cost-effectiveness of Cerebral Protection During TAVR: Can We Justify Systematic Use?

Presenter: Eberhard Grube, Tamim Nazif, Hemal Gada

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Strokes After Transfemoral TAVR vs SAVR: A Propensity-Matched Analysis From the PARTNER Trial

Presenter: Eberhard Grube, Tamim Nazif, Chetan P. Huded

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Strokes After TAVR (and SAVR): Incidence in the "Modern Era" and Key Messages From NeuroARC

Presenter: Eberhard Grube, Tamim Nazif, Alexandra J. Lansky

June 21, 2018

Presentation EuroPCR 2018

Anatomical Predictors of Stroke Prevention During Transcatheter Aortic Valve Implantation: The SENTINEL Trial

Presenter: Hasan Jilaihawi

May 23, 2018

Presentation SCAI 2018

Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes After Percutaneous Coronary Intervention: A Subgroup analysis of the Prevention of Serious Adverse Events Following Angiography (PRESERVE) Trial

Presenter: Santiago Garcia

April 28, 2018

Presentation ACC 2018

CANTOS: Anti-Inflammatory Therapy with Canakinumab for the Prevention and Management of Diabetes

Presenter: Brendan M. Everett

March 12, 2018

Presentation ACC 2018

Hospital Readmission Following Perioperative Myocardial Infarction Associated with Non-Cardiac Surgery

Presenter: Nathaniel R. Smilowitz

March 11, 2018

Advertisement

Impact of Smoking Status on Outcomes After Percutaneous Coronary Intervention

Advances in Digital Health May Help Prevent Cardiovascular Diseases: "E-Prevention"

COMPASS Trial Revisited: Weighing Rivaroxaban Secondary Prevention vs DAPT After PCI

LAA Closure 3: Prevention and Management of Complications

Topic 5: CIN Prevention Strategies

PFO Closure for Primary Prevention?

Incidence, Predictors, Consequences, Prevention, and Treatment of Coronary Occlusion During TAVR: Practical Clinical Guidelines

NO: The Data Are Weak and the Costs Are Prohibitive!

YES: Review of ALL the Data and Common Sense Tell the Story!

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Cedars-Sinai Medical Center (USA)

Erasmus University (The Netherlands)

Ulm University (Germany)

Cost-effectiveness of Cerebral Protection During TAVR: Can We Justify Systematic Use?

Strokes After Transfemoral TAVR vs SAVR: A Propensity-Matched Analysis From the PARTNER Trial

Strokes After TAVR (and SAVR): Incidence in the "Modern Era" and Key Messages From NeuroARC

Anatomical Predictors of Stroke Prevention During Transcatheter Aortic Valve Implantation: The SENTINEL Trial

Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes After Percutaneous Coronary Intervention: A Subgroup analysis of the Prevention of Serious Adverse Events Following Angiography (PRESERVE) Trial

CANTOS: Anti-Inflammatory Therapy with Canakinumab for the Prevention and Management of Diabetes

Hospital Readmission Following Perioperative Myocardial Infarction Associated with Non-Cardiac Surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content